TABLE 1.

Key characteristics of the MOFs involved in this article.

MOFs	Metal	Component	Drug	Surface functionalization	Ref
MINPs	Mn2+	porphyrin, ICG	—	—	Shi et al. (2018)
ZIF-8@Ce6–HA	Zn2+	2-Methylimidazole	Ce6	HA	Fu et al. (2020)
DOX@NPMOF	Zr2+	TCPP	DOX	—	Liu et al. (2017)
PEG-Au/FeMOF@CPT	Zr2+	TCPP	CPT	Au NPs,C12SH,PEG-SH	Ding et al. (2020)
CDZs	Fe2+, Zn2+	2-Methylimidazole	DHA	Cancer cell membrane	Xiao et al. (2020)
LA-GA-NMOF	Zr4+	UiO-66-NH2	DOX	FA, LA, GA	Fytory et al. (2021)
UiO-66/Bi2S3@DOX	Bi3+	UiO-66	DOX	—	Liu et al. (2022)
NH2-MIL-53(Al)NMOF	Al3+	2-Aminoterephthalic acid	DOX	LA	Samui et al. (2019)
As@ZIF-8/PEG	Zn2+	2-Methylimidazole	ATO	COOH-PEG-COOH	Chen et al. (2022)
DOX@Fe3O4-ZIF-8	Fe2+, Zn2+	2-Methylimidazole	DOX	—	Cheng et al. (2019)
TPL@CD-MOF	K+	CD	TPL	—	Li Z et al. (2022)
SOR@PPF	Zn2+	TCPP	SOR	—	Bieniek et al. (2021)
LA-AuNR/ZIF-8	Zn2+	2-Methylimidazole	DOX	Au nanorod, LA	Zhang H et al. (2019)
MIL-101(Fe)@SOR	Fe3+	2-Aminoterephthalic acid	SOR	—	Liu et al. (2021b)
(DOX+ACE)@ZIF-8	Zn2+	2-Methylimidazole	DOX, ACE	—	Jing et al. (2021)
MOF-RB	Zr2+	UiO-66-NH2	RB	—	Sun Q.X et al. (2021)
HCPT@NMOFs-RGD	Zr4+	TCPP	HCPT	RGD peptide	Shang et al. (2022)
FA-NPMOF	Gd3+	TCPP	FA	—	Chen et al. (2019)